Characteristics and immunological changes of tumor-infiltrating lymphocytes during neoadjuvant chemo-immunotherapy in epithelial ovarian cancer

被引：0
|
作者：
Park, Junsik [1 ]
Kim, Yup [1 ]
Lee, Jung-Yun [2 ]
Kim, Sunghoon [1 ]
Lee, Yong Jae [1 ]
Kim, Sang Wun [1 ]
机构：
[1] Yonsei Univ, Coll Med, Seoul, South Korea
[2] Yonsei Univ Hlth Syst, Seoul, South Korea
来源：
GYNECOLOGIC ONCOLOGY | 2022年 / 166卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
251
引用
收藏
页码：S135 / S135
页数：1
相关论文
共 50 条
  • [31] Changes in Tumor-Infiltrating Lymphocytes and Vascular Normalization in Breast Cancer Patients After Neoadjuvant Chemotherapy and Their Correlations With DFS
    Wang, Qiong
    Xiang, Qun
    Yu, Lan
    Hu, Ting
    Chen, Yangyang
    Wang, Jue
    Nie, Xiu
    Cheng, Jing
    FRONTIERS IN ONCOLOGY, 2020, 9
  • [32] Determination of Tumor-infiltrating CD8+ Lymphocytes in Human Ovarian Cancer
    Aust, Stefanie
    Bachmayr-Heyda, Anna
    Pils, Dietmar
    Zhao, Lijun
    Tong, Weimin
    Berger, Astrid
    Fogel, Mina
    Thalhammer, Theresa
    Sehouli, Jalid
    Horvat, Reinhard
    Zeillinger, Robert
    Castillo-Tong, Dan C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2013, 32 (03) : 269 - 276
  • [33] Influence of neoadjuvant radio-chemotherapy on tumor-infiltrating lymphocytes in squamous esophageal cancer
    Zingg, U.
    Montani, M.
    Frey, D. M.
    Dirnhofer, S.
    Went, P.
    Oertli, D.
    EJSO, 2009, 35 (12): : 1268 - 1272
  • [34] Tumor-infiltrating lymphocytes are important pathologic predictors for neoadjuvant chemotherapy in patients with breast cancer
    Yamaguchi, Rin
    Tanaka, Maki
    Yano, Ayako
    Tse, Gary M.
    Yamaguchi, Miki
    Koura, Keiko
    Kanomata, Naoki
    Kawaguchi, Atsushi
    Akiba, Jun
    Naito, Yoshiki
    Ohshima, Koichi
    Yano, Hirohisa
    HUMAN PATHOLOGY, 2012, 43 (10) : 1688 - 1694
  • [35] Tumor-infiltrating Cytotoxic T Lymphocytes as Independent Prognostic Factor in Epithelial Ovarian Cancer With Wilms Tumor Protein 1 Overexpression
    Vermeij, Renee
    de Bock, Geertruida H.
    Leffers, Ninke
    ten Hoor, Klaske A.
    Schulze, Ute
    Hollema, Harry
    van der Burg, Sjoerd H.
    van der Zee, Ate G. J.
    Daemen, Toos
    Nijman, Hans W.
    JOURNAL OF IMMUNOTHERAPY, 2011, 34 (06) : 516 - 523
  • [36] Tumor-infiltrating lymphocytes are an important pathological predictor for neoadjuvant chemotherapy in patients with breast cancer
    Yamaguchi, R.
    Tanaka, M.
    Yano, A.
    Yamaguchi, M.
    Yano, H.
    BREAST, 2011, 20 : S76 - S76
  • [37] Impact of Tumor-Infiltrating Lymphocytes in Breast Cancer Patients with Neoadjuvant Chemotherapy Depends on Subtypes
    Matsumoto, Akiko
    Jinno, Hiromitsu
    Ishida, Hiroki
    Hiraiwa, Kunihiko
    Nakamura, Tetsuya
    Ueyama, Yoshihito
    Saito, Junichi
    ANNALS OF ONCOLOGY, 2016, 27
  • [38] Change of Tumor-Infiltrating Lymphocytes after Neoadjuvant Chemotherapy & Their Clinical Significance in Breast Cancer
    Lee, Mieson
    Kim, Bo-Im
    Bang, Won Seon
    Gong, Gyungyub
    Lee, Hee Jin
    MOLECULAR THERAPY, 2019, 27 (04) : 389 - 389
  • [39] Tumor-infiltrating lymphocytes and PD-L1 expression in pre- and post-treatment ovarian cancer during neoadjuvant chemotherapy
    Lee, Yong Jae
    Woo, Ha Young
    Nam, Eun Ji
    Kim, Sang Wun
    Kim, Sunghoon
    Kim, Young Tae
    Joung, Je-Gun
    Lee, Jung-Yun
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S136 - S137
  • [40] Predictive value of tumor-infiltrating lymphocytes for response to neoadjuvant chemotherapy and breast cancer prognosis
    Li, Xiaomin
    Tan, Qiuwen
    Li, Hongjiang
    Yang, Xiaoqin
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (01) : 89 - 95
12345